文献速递脑血管病

配对迷走神经刺激治疗卒中后两年疗效维持:VNS-REHAB随机临床试验随访

Two-Year Retention of Benefits After Paired Vagus Nerve Stimulation in Stroke: Follow-Up of the VNS-REHAB Randomized Clinical Trial.
PubMed 文献 · Neurology · 2026-07-14

VNS-REHAB试验的事后分析显示,慢性缺血性卒中患者在接受配对迷走神经刺激(VNS)联合康复治疗后,继续自我激活主动刺激至少2年,49例患者2年时FMA-UE评分较基线改善7.51分(95%CI 5.80-9.22;p<0.001),WMFT评分改善0.63分(0.50-0.75;p<0.001),7项参与和生活质量指标中5项显著改善,16例亚组3年时改善仍维持。

要点

  • 配对VNS联合康复可使慢性缺血性卒中患者上肢功能改善维持至少2年。
  • 2年时FMA-UE较基线改善7.51分,WMFT改善0.63分,差异均显著。
  • 部分患者3年时仍维持改善,提示疗效可持续。

核心结论

  • 配对VNS联合康复对慢性缺血性卒中患者上肢损伤和功能的改善可维持至少2年,是特定慢性手臂和手部功能障碍患者的重要治疗选择。

研究设计与样本

  • VNS-REHAB关键试验的事后分析,采用三盲、假对照、随机设计。
  • 参与者接受真实(Active)或假(Control)VNS的全治疗方案后,继续自我激活主动刺激至少2年。
  • 2年汇总结局数据来自49例参与者,3年数据来自16例亚组参与者。

主要发现

  • 2年时FMA-UE评分较基线改善7.51分(95%CI 5.80-9.22;p<0.001)。
  • 2年时WMFT评分较基线改善0.63分(95%CI 0.50-0.75;p<0.001)。
  • 2年时7项参与和生活质量指标中5项较基线显著改善。
  • 16例亚组参与者3年时仍维持改善。

临床怎么用

  • 对于慢性缺血性卒中后手臂和手部功能障碍的特定患者,配对VNS联合康复可作为维持长期功能改善的治疗选项。

局限性

  • 本研究为事后分析,2年汇总数据仅来自49例参与者,3年数据仅来自16例亚组参与者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Vagus nerve stimulation (VNS) paired with rehabilitation improves short-term upper extremity (UE) function in people with chronic ischemic stroke. Because sustained improvements are needed for people with stroke, we examined the long-term effects of Paired VNS on impairment, activity, participation, and quality of life. METHODS: This is a post hoc analysis of 2-year data of the triple-blind, sham-controlled, randomized VNS-REHAB pivotal trial. After receiving the full therapeutic protocol with either real (Active) or sham (Control) VNS, participants continued self-activated active stimulation for at least 2 years. The Fugl-Meyer Assessment-Upper Extremity (FMA-UE), Wolf Motor Function Test (WMFT), participation, and quality of life outcomes were assessed at multiple time points. RESULTS: Pooled 2-year outcome data were available from 49 participants. At the 2-year point, FMA-UE scores improved 7.51 points (95% CI 5.80-9.22; p < 0.001), and WFMT scores improved 0.63 points (0.50-0.75; p < 0.001) from baseline. There were significant improvements from baseline in 5 of 7 participation and quality of life measures at 2 years. Improvements were retained at 3 years among a subset of participants (n = 16). DISCUSSION: The sustained improvements in UE impairment and function for at least 2 years make this an important treatment option for a defined subset of individuals with chronic arm and hand deficits after ischemic stroke. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov/study/NCT03131960.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kimberley TJ, Vora I, Cramer SC, et al. Two-Year Retention of Benefits After Paired Vagus Nerve Stimulation in Stroke: Follow-Up of the VNS-REHAB Randomized Clinical Trial. Neurology. 2026. PMID: 42447422. doi:10.1212/WNL.0000000000218298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。